Product Name   :    Aprepitant 43% Pellets
Dosage Form   :    Capsules
Dose   :    40mg, 80mg, 125mg
Therapeutic Category   :    Antiemetic
Reference Product   :    Emend
API : DMF; Dossier — CTD   :    Available
Trade Name   :    Emend
Originator   :    Merck & Co
Aprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). This medication is also used to prevent nausea and vomiting after surgery. Aprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting.
Aprepitant (brand name: Emend (the brand name used in all English-speaking countries)) is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor. Aprepitant is manufactured by Merck & Co. under the brand name Emend for prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) and for prevention of postoperative nausea and vomiting. It was approved by the FDA in 2003.